Amycolatopsis mediterranei (Margalith and Beretta) Lechevalier et al.
商品貨號
B168440
Deposited As
Streptomyces mediterranei Margalith and Beretta
Strain Designations
RS/20
Application
Produces rifamycin SV
Biosafety Level
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
freeze-dried
Disclosure
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC.
Lancini G, Hengeller C. Preparation of the antibiotic rifamycin SV. US Patent 3,597,324 dated Aug 3 1971
Lechevalier MP, et al. Two new genera of nocardioform Actinomycetes: Amycolata gen. nov. and Amycolatopsis gen. nov.. Int. J. Syst. Bacteriol. 36: 29-37, 1986.
